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Gait Mechanics Are Different Between Healthy Controls  
and Patients With Multiple Sclerosis
Jessie M. Huisinga,1 Kendra K. Schmid,2 Mary L. Filipi,2 and Nicholas Stergiou2,3
1University of Kansas Medical Center; 2University of Nebraska Medical Center;  
3University of Nebraska at Omaha
Multiple sclerosis (MS) causes severe gait problems in relatively young individuals, yet there have been 
limited studies to quantitatively identify the specific gait parameters that are affected. The purpose of this 
study was to define any differences in biomechanical gait parameters between patients with MS and healthy 
controls. A total of 31 MS patients and 31 healthy controls were evaluated: joint torques and joint powers 
were calculated at the ankle, knee, and hip during the stance phase of gait. The self-selected walking velocity 
was used as a covariate in the analysis to ensure that group differences were not due to differences in walking 
velocity between the MS and healthy control groups. Reduced angular range, less joint torque, and reduced 
joint power were seen in patients with MS. We also found significant correlations between biomechanical 
gait parameters and EDSS score, which provides a clinical rating of disease severity. Our findings provide 
a quantitative assessment of the gait mechanics employed in patients with MS. The altered lower extremity 
mechanics observed in patients with MS reflect both a neurological and strength deficit compared with healthy 
controls during walking.
Keywords: joint kinetics, neurological disease, gait velocity, lower extremity
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Multiple sclerosis (MS) is an autoimmune disease 
that causes progressive neurodegeneration and is com-
monly diagnosed in young adults between 20 and 40 
years old.1 Symptoms vary widely within individuals 
with MS, but commonly reported symptoms include 
sensory disturbances, limb weakness, clumsiness, gait 
ataxia, and cognitive deficits.2 There is a demonstrated 
need for a mechanism to identify gait abnormalities in the 
early stages of the disease, before the onset of a clinical 
disability, which could provide better classification for 
MS patients and for targeting more aggressive therapies.3 
The disease severity and the clinical classification of 
movement disability in MS patients are typically mea-
sured using the Kurtzke Disability Scale (EDSS). This 
scale rates patients on a 20 point scale through a series 
of functional system tests.4 While the scale provides the 
clinician with a general perception of the patient’s level 
of disability, it does not provide information regarding 
the quality of gait or any other associated movement 
problems.
Quantitative evaluation of gait in the form of joint 
mechanics may provide one solution to this problem.5 
This analysis has been used extensively to characterize 
gait abnormalities in different populations and to guide 
treatment or to assess outcomes.6–12 Specifically, evalu-
ation of joint torques and powers allows for the quan-
tification of the relative contribution of muscle groups 
during a movement, as well as the identification of the 
specific type of muscular contraction (ie, concentric or 
eccentric) that is controlling the joint motion. However, 
in patients with MS, relatively few studies have used 
such methodology to examine gait characteristics. Pre-
vious studies describe the ground reaction force and 
joint angle patterns13 and balance control during gait 
initiation in patients with MS.14 Recently, Kelleher et 
al15 used kinematics, ground reaction forces and EMG 
in MS patients and reported reduced gait speed, reduced 
maximum hip and knee extension, ankle plantar flexion 
angle and propulsive force compared with the control 
group. Wurdeman and colleagues16 examined ground 
reaction forces to describe differences in the frequency 
component between MS patients and healthy controls. 
Finally, relationships between gait mechanics and fatigue 
and quality-of-life measures have been identified.17 While 
these studies have successfully used biomechanical data 
to begin to identify specific gait patterns in MS patients, 
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evaluating joint torques and powers to investigate joint 
muscular responses and their contributions can provide 
fundamental understanding of the mechanics of walk-
ing in individuals with neuromuscular pathologies. 
This information may allow for a better understanding 
of how varying symptoms relate to gait problems, how 
the progression of the disease affects gait, and to a clas-
sification of the different neuromuscular adaptations 
that underlie any alterations in gait mechanics. Thus, 
this study extends previous work by examining joint 
torques and powers during gait that allow for specific 
determination of muscular contributions and responses 
at each joint. This study also uses walking velocity as a 
covariate in the analysis to determine whether the gait 
differences observed between the groups are influenced 
by differences in walking velocity across the groups. 
Finally, this study examines the relationship between the 
gait parameters of MS patients and their clinically defined 
EDSS scores to determine whether biomechanical gait 
parameters are related to disease severity.
It was hypothesized that MS patients would exhibit 
reduced joint torques and powers at the ankle, knee, and 
hip compared with healthy age-matched controls. This 
prediction was made based on the previously reported 
spatial temporal alterations in MS patients where stride 
lengths were found to be shorter and double support times 
were found to be longer in MS patients.3,13,18 Such spatial 
and temporal alterations are likely related to changes in 
joint torques and powers of MS patients. In addition, it 
was hypothesized that there would be significant cor-
relations between gait parameters and EDSS scores 
since patients with are assigned higher EDSS scores as 
mobility decreases.4
Methods
Subjects
Thirty-one MS patients and 31 healthy controls par-
ticipated in this study (Table 1). All procedures were 
approved by the University’s Medical Center Institu-
tional Review Board. Participants were recruited through 
the University Medical Center’s Neurology clinic and 
referrals from private practice neurology clinics. Control 
subjects were recruited through family members of MS 
subjects and advertisement in the community to match 
for age and sex. Exclusion criteria for the MS subjects 
included inability to give informed consent, an Expanded 
Disability Status Scale (EDSS) score greater than or equal 
to 6.5, completion of treatment for relapse less than 30 
days before study participation, and any other neurologi-
cal or vestibular disorder. MS subjects were not excluded 
for taking any approved disease-modifying therapy for 
MS19 but subjects taking the symptom-modifying medica-
tion Fampridine were excluded since it has been shown 
to specifically affect gait.20
Data Collection Protocol
Patients were prepared for collection by wearing a 
form-fitting outfit and obtaining anthropometric data. 
Reflective markers were placed bilaterally according 
to anatomical positions using a modified Helen Hayes 
marker set.21 The initial starting point for the walking 
trials was determined so that the subject could strike the 
force platform, which was in the middle of the walkway, 
with only one foot. During each trial, the subject walked 
at self-selected pace over a 10 m walkway while three-
dimensional marker trajectories (EvaRT 5.0, Motion 
Analysis Corp., Santa Rosa, CA, sampling at 60 Hz) and 
ground reaction forces (Kistler force platform, Model 
9281B11; Amherst, NY, sampling at 600 Hz) were simul-
taneously collected. Subjects rested for a minimum of 
one minute between each trial. The process was repeated 
to obtain five good walking trials with the patient’s foot 
landing completely within the force plate without altering 
the stride, and then the other limb was collected using 
the same process. Data collection procedures for MS 
patients and for healthy controls were identical. Joint 
angle, torque, power variables and walking speed were 
calculated for each trial and the average value across all 
5 trials for each leg was used for analysis. This resulted 
in one value for each variable for each leg. All subjects 
walked at self-selected pace to ensure that the natural 
walking pattern was captured since self-selected pace 
is the most stable during walking22 and in MS patients, 
Table 1 Demographic information for MS patients and healthy 
controls
MS Patients (n = 31) Healthy Controls (n = 31)
Sex (M/F) 5 male, 26 female 8 male, 23 female
Age 46.2 ± 10.6 y 42.0 ± 12.5 y
EDSS 2.6 ± 0.7 (range 1.0–4.0) —
Height (cm) 165.3 ± 6.7 170.6 ± 18.8
Mass (kg) 78.1 ± 15.8 77.2 ± 11.04
Walking Velocity (m/s)* 1.06 ± 0.21 1.21 ± 0.22
*P < .05, significant difference in walking velocity between MS patients and healthy controls.
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walking at a faster than preferred pace results in increased 
metabolic cost.23 The ranges of walking speeds were 
0.68–1.42 m/s for MS subjects and 0.69–1.55 m/s for 
controls.
Data Analysis
A low-pass second order Butterworth digital filter with 
a 7 Hz cutoff was used to smooth the marker trajectories 
during postprocessing. Inverse dynamics were applied 
using custom MATLAB programs to calculate the peak 
flexor and extensor torques for the ankle, knee, and hip 
joints in the sagittal plane based on algorithms described by 
Winter.5 The joint torques and muscle powers (Tables 2–4) 
were normalized to the subject’s body mass. The gait cycle 
definitions and procedures followed for identifying these 
parameters have been outlined in other gait studies.6,24–26
Statistical Analysis
Linear mixed effects modeling was used to evaluate 
differences in mean joint angles, torques, and powers 
between groups. Group, velocity, and the interaction 
between group and velocity were included in the model 
as fixed effects. In this way, the model allowed for iden-
tification of variables that were different as a result of 
group, regardless of walking velocity differences between 
groups. Because both limbs of each subject were used 
for analysis, random effects were included in the model 
to account for the correlation between limbs of the same 
subject. Spearman correlations were performed between 
each joint angle, torque, and power variable and the MS 
patient EDSS score. Spearman correlations were used 
because the distribution of EDSS scores was not normal 
according to the Shapiro-Wilk test (P = .027). Statistical 
analyses were performed using SAS version 9.2. Statisti-
cal significance was set at α = .05.
Results
At the ankle, peak plantar flexion angle in early stance 
(APF_ES) was significantly lower (F = 10.95, P = .016) 
and peak plantar flexion angle at toe-off (APF_TO) was 
significantly lower (F = 5.51, P = .022) in MS patients. 
APF_TO significantly correlated (P < .001) with EDSS 
score in MS patients. There were no significant differ-
ences between groups found in knee joint motion. How-
ever, peak knee flexion angle (KFLX) and knee range of 
motion (KROM) significantly correlated (P = .001; P = 
.012 respectively) with EDSS score in MS patients. At 
the hip, extension (HEXT) at terminal stance, was also 
significantly lower (F = 4.64, P = .034) in MS patients. 
There was a significant interaction between group and 
Table 2 Joint angle results between MS patients (MS) and healthy 
controls (HC)
MS Mean (SD) HC Mean (SD)
Paired Test
P-Value
MS 
Correlation
with EDSS
Joint Angles (Degrees)
 APF_ES –5.47 (3.62) –6.58 (2.37) 0.016* –0.019
 ADF 12.74 (3.52) 11.28 (3.37) 0.142 –0.065
 APF_TO –13.53 (5.56) –16.88 (4.73) 0.022* –0.593‡
 AROM 18.12 (3.94) 17.78 (3.24) 0.956 –0.077
 KFLX 13.94 (5.60) 13.88 (5.67) 0.349 –0.565‡
 KEXT 4.97 (4.10) 4.31 (3.84) 0.348 –0.289
 KROM 9.33 (3.88) 9.79 (4.19) 0.437 –0.477‡
 HFLX 25.18 (4.62) 27.35 (4.57) 0.088 –0.532‡
 HEXT –10.42 (4.53) –11.91 (4.23) 0.034*† –0.174
 HROM 35.58 (4.91) 39.26 (3.84) 0.001*† –0.635‡
*P < .05, significant difference between MS and HC.
†P < .05, significant effect of walking velocity on difference.
‡P < .05, significant correlation between gait variable and EDSS score.
APF_ES—peak ankle plantar flexion angle during early stance; ADF—peak ankle dorsiflexion angle during 
late stance; APF_TO—peak ankle plantar flexion angle at toe-off; AROM—total angle range of motion during 
stance phase; KFLX—peak knee flexion angle during stance; KEXT—peak knee extension angle during stance; 
KROM—total knee range of motion during stance phase; HFLX—peak hip flexion angle during early stance; 
HEXT—peak hip extension angle during late stance; HROM—total hip range of motion during stance phase.
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Table 3 Joint torque results between MS patients (MS) and healthy 
controls (HC)
MS Mean (SD) HC Mean (SD) P-Value
MS Correlation
with EDSS
Joint Torques (N·m/kg)
 ADT –0.267 (0.072) –0.381 (0.163) 0.002* –0.296
 APT 1.195 (0.141) 1.354 (0.219) <0.001* –0.297
 KET 0.490 (0.203) 0.709 (0.236) 0.009* –0.580‡
 KFT –0.291 (0.154) –0.256 (0.232) 0.086 –0.013
 HET 0.650 (0.207) 0.789 (0.238) 0.157 0.062
 HFT –0.765 (0.189) –0.975 (0.277) 0.003* 0.148
*P < .05, significant difference between MS and HC.
‡P < .05, significant correlation between gait variable and EDSS score.
ADT—peak ankle dorsiflexor torque during early stance; APT—peak ankle plantar flexor torque during late 
stance; KFT—peak knee flexor torque during stance; KET—peak knee extensor torque during stance; HFT—
peak hip flexor torque during late stance; HET—peak hip extensor torque during early stance.
Table 4 Joint Power results between MS patients (MS) and Healthy 
Controls (HC).
MS Mean (SD) HC Mean (SD) P-Value
MS Correlation
with EDSS (ρ)
Joint Powers (W/kg)
 A1 –0.398 (0.196) –0.601 (0.261) 0.015* –0.409‡
 A2 2.440 (0.668) 3.121 (0.874) 0.008*† –0.574‡
 K1 –0.675 (0.353) –1.021 (0.430) 0.006* –0.595‡
 K2 0.436 (0.276) 0.533 (0.308) 0.492 –0.398‡
 K3 –0.511 (0.217) –0.857 (0.594) 0.019*† –0.173
 H1 0.460 (0.238) 0.617 (0.298) 0.073 –0.104
 H2 –0.651 (0.253) –0.903 (0.366) 0.016* –0.497‡
 H3 0.495 (0.114) 0.672 (0.321) 0.014* –0.109
*P < .05, significant difference between MS and HC.
†P < .05, significant effect of walking velocity on difference.
‡P < .05, significant correlation between gait variable and EDSS score.
Note. Negative joint power values indicate power absorption, and positive values indicate power generation.
A1—peak ankle power absorption in early stance; A2—peak ankle power generation in late stance; K1—peak 
knee power absorption in early stance; K2—peak knee power generation in midstance; K3—peak knee power 
absorption in late stance; H1—peak hip power generation in early stance; H2—peak hip power absorption in 
late midstance; H3—peak hip power generation in late stance.
velocity for HEXT (F = 4.35, P = .041), which showed 
that at slow walking velocities HEXT was significantly 
lower (t = 2.01, P = .049) in patients with MS but at faster 
walking velocities, there was no difference (t = 0.79, P = 
.434). Peak hip flexion (HFLX) significantly correlated 
(P = .002) with EDSS score in MS patients. Total hip 
range of motion (HROM) was significantly lower (F = 
18.08, P < .001) in MS patients. There was a significant 
interaction between group and velocity for HROM (F 
= 14.25, P = .003), which showed that at slow walking 
velocities HROM was significantly lower (t = 4.69, P = 
.001) in patients with MS but at faster walking velocities, 
there was no difference (t = 0.04, P = .967). HROM also 
significantly correlated (P < .001) with EDSS score in 
MS patients such that subjects with higher EDSS scores 
had lower HROM.
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At the ankle, dorsiflexor torque during early stance 
(ADT) and plantar flexor torque during late stance (APT) 
were significantly lower (F = 10.50, P = .002; F = 13.73, 
P < .001; respectively) in MS patients (Figure 1, top). 
The knee extensor torque (KET) during early stance was 
significantly lower (F = 7.29, P = .009) and hip flexor 
torque (HFT) during late stance was significantly lower 
(F = 9.35, P = .003) in MS patients (Figure 1, middle 
and bottom). KET was significantly correlated (P = .001) 
with EDSS score in MS patients. Importantly, none of 
these joint torque differences were affected by the group 
difference in walking velocity, which indicates significant 
differences between groups was not because the groups 
walked at different speeds (Table 3).
Figure 1 — Joint torque mean ensemble curves for the healthy 
controls (identified with gray lines) and the MS patients (identi-
fied with black lines) at normal walking velocity. Significant 
differences (P < .05) between groups for the parameters selected 
are identified with an asterisk (*). ADT is peak ankle dorsiflexor 
torque during early stance. APT is peak ankle plantar flexor 
torque during late stance. KET is peak knee extensor torque 
during stance. HFT is peak hip flexor torque during late stance.
Figure 2 — Joint power mean ensemble curves for the healthy 
controls (identified with gray lines) and the MS patients (identi-
fied with black lines) at normal walking velocity. Significant 
differences (P < .05) between groups for the parameters selected 
are identified with an asterisk (*). A1 is the ankle power absorp-
tion during early stance. A2 is the ankle power generation during 
late stance. K1 is the knee power absorption during early stance 
and K3 during late stance. H2 is the hip power absorption at 
midstance and H3 is the hip power generation during late stance.
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The ankle power absorption during early stance (A1) 
and the ankle power generation during late stance (A2) 
were significantly lower (F = 6.22, P = .015; F = 7.63, P 
= .008; respectively) in MS patients (Figure 2, top). Both 
A1 and A2 were significantly correlated (P = .022; P = .001 
respectively) with EDSS score in MS patients. There was a 
significant interaction between group and velocity for A2 
(F = 4.88, P = .03), which showed that at lower walking 
velocities, A2 was significantly lower (t = 3.64, P = .006) in 
MS patients, but at faster walking velocities, the difference 
between MS patients and controls was no longer significant 
(t = 1.14, P = .260) (Figure 3, left). Knee power absorption 
during early stance (K1) (F = 8.27, P = .006) and during 
late stance (K3) (F = 5.93, P = .019) were both significantly 
lower in the MS patients (Figure 2, middle). K1 and K2 
(peak knee power generation during midstance) were both 
significantly correlated (P < .001, P = .027 respectively) 
with EDSS score in MS patients. There was a significant 
interaction between group and velocity for K3 (F = 9.29, P 
= .004), which showed that at slower walking velocity there 
was no difference (t = 0.87, P = .391) between patients with 
MS and controls but at faster walking velocities, K3 was 
significantly lower (t = 4.04, P = .002) in patients with MS 
(Figure 3, right). Hip power absorption at midstance (H2) 
was significantly lower (F = 6.19, P = .16) and hip power 
generation during late stance (H3) was significantly lower 
(F = 6.58, P = .014) in MS patients (Figure 2, bottom). H2 
was significantly correlated (P = .004) with EDSS score in 
MS patients. None of the power differences at the hip were 
affected by the walking velocity differences between the 
MS patients and the controls, which indicates the significant 
differences between groups was not because the groups 
walked at different speeds.
Discussion
This study demonstrates that joint torques and powers 
during walking in MS patients are significantly altered 
compared with healthy controls when walking velocity 
was considered as a covariate in the analysis and indicates 
that differences between the two groups were independent 
of walking velocity differences. Our results agree with 
the original hypothesis that MS patients would exhibit 
reduced joint torques and powers compared with controls. 
In addition, there were several significant relationships 
identified between gait variables and the EDSS score for 
MS patients that indicate that the biomechanical gait vari-
ables are related to clinical measures of disease severity.
At the ankle, dorsiflexor torque during the loading 
response (ADT) was reduced in MS patients. This could 
occur if the resultant ground reaction force vector is 
closer to the ankle joint center during loading.5 During 
early stance, there was a reduced plantar flexion at the 
beginning of single limb stance and overall significantly 
reduced hip range of motion. These results indicate that 
the ground reaction force vector likely remained closer to 
the ankle joint during weight acceptance. Thus, patients 
with MS could exhibit a gait pattern with the foot landing 
on the ground in a less plantar-flexed position. Overall, 
this joint position could reduce the requirement of the 
ankle dorsiflexors to control the plantar flexion movement 
during early stance. This is also evident by the significant 
reduction in the ankle power absorption (A1) during early 
stance, which reveals a decreased eccentric contraction 
by the MS patients. This decreased contraction could be 
the result of changes in joint geometry at or shortly after 
touchdown, or it may suggest a decreased neuromuscular 
ability to control the plantar flexion movement during 
early stance.
Peak ankle plantar flexor torque was significantly 
reduced in MS patients during terminal stance, which led 
to a reduced concentric contraction of the plantar flexors 
as revealed by the ankle power generation (A2) during 
preswing (push-off power). While peak dorsiflexion 
angle during late stance was not different, peak plantar 
flexion at toe-off was significantly lower in MS patients, 
so the angular distance traveled by the ankle is lower 
and the amount of torque generated (APT) was reduced. 
Figure 3 — Scatter plots to represent the significant interactions between specific joint power variables and walking velocity. The 
gray lines are for the healthy control group and the black lines are for the MS patients group. The left graph illustrates interaction 
(P = .03) between walking velocity and peak ankle power generation during late stance (A2); the right graph illustrates interaction 
(P = .003) between walking velocity and peak knee power absorption during late stance (K3).
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The reduction in plantar flexor torque will result in an 
inability to support forward progression of the trunk and 
to properly initiate the swing phase of gait.27 In addition 
to supporting trunk progression and initiating the swing 
phase of gait, ankle power generation has been reported as 
the strongest predictor of step length in elderly subjects28 
and has been found to correlate positively with gait veloc-
ity and stride length in older persons.5 Control subjects 
walked faster than MS patients, but there was a significant 
interaction between walking velocity and group (MS 
vs. control) for ankle power generation (Figure 3, left). 
This suggests that fast walking MS patients were able to 
increase ankle power generation and achieve concentric 
contractions at the ankle. It is possible that the evalua-
tion of ankle power generation could reflect severity of 
gait disturbance in persons with MS. Such a conclusion 
is supported by the strong relationship between A2 and 
EDSS score, which reflects clinically rated neurological 
impairment. In addition, peak ankle torque at late stance 
showed no group by velocity interaction. Because ankle 
joint power was affected by walking velocity but peak 
ankle torque was not, only angular velocity of the segment 
changed at different walking speeds. This may indicate 
that subjects able to walk faster could also increase 
the angular velocity of the segment, which resulted in 
increased ankle power at late stance and is a possible 
indication of better segment control through muscle 
firing. It seems the interaction observed is likely more 
neurological in nature than muscular, but this conclusion 
must be investigated further by identifying any changes 
in muscle strength through dynamometer use and by 
examining EMG changes during walking.
At the knee, extensor torque (KET) was significantly 
reduced during early/midstance and power absorption 
(K1) was reduced during early stance. During early 
stance, the knee functions as a shock absorber by flex-
ing and eccentrically absorbing power.29 The reduction 
in K1 in patients with MS indicates that while peak knee 
flexion angle was not different, the neural control of the 
knee flexors was impaired so the eccentric control of 
knee flexion was reduced. There was a strong relationship 
between K1 and EDSS score for MS patients, which could 
indicate that if K1 is reflective of reduced neural control 
of the knee flexors, then patients with higher EDSS 
scores (greater neurological impairment) have reduced 
neural control of lower extremity muscles. During late 
stance, the knee extensors again eccentrically control 
knee flexion and absorb power. However, power absorp-
tion during late stance (K3) was significantly reduced in 
MS patients. The inability to control knee flexion by the 
extensor muscles may be the result of neuromuscular 
control deficits in the MS patients since knee flexion and 
extension angles were unchanged. During late stance, 
with reduced ankle power generation there is reduced 
energy transferred up the kinetic chain to the knee. With 
less energy transferred up to the knee by the ankle plan-
tar flexors, there is less power that needs to be absorbed 
at the knee; thus K3 is reduced. Such an explanation is 
also supported by Judge et al,28 who interpreted power 
absorption at the knee as a natural consequence of the 
energy transferred between the ankle and knee.
There was a significant interaction between walking 
velocity and group for K3, where in the MS group, as 
walking velocity increased, K3 values did not increase 
but in controls K3 did increase with velocity (Figure 3, 
right). The interaction indicates a different neuromuscular 
strategy for the patients with MS. Interestingly, there was 
also a significant interaction between walking velocity A2 
mentioned earlier. The relationship between A2 and K3 
is such that if A2 increased with velocity then K3 should 
also increase with walking velocity but instead, K3 did 
not increase with walking velocity in the MS group. This 
disagreement may be due to an inability of the MS group 
to actively control (eccentric muscle contraction) knee 
flexion by the knee extensor muscles as walking velocity 
increases. This finding suggests that the MS patients who 
were able to walk faster were still not able to increase 
power absorption at the knee and achieve the necessary 
eccentric contractions of the knee extensors. Therefore, 
knee power absorption (K3) is equally affected regard-
less of the severity level, since K3 does not increase with 
increasing walking velocity as it does in controls.
Hip joint motion showed reduced peak extension 
angle (HEXT) and total range of motion (HROM) in 
MS patients. Reduced HEXT limits the progression 
of the trunk over the leg during stance and results in 
significantly reduced flexion torque (HFT) during late 
stance. Both HEXT and HROM during stance showed 
an interaction between group and walking velocity. This 
effect of velocity at the hip was not seen in joint torque or 
power measures, which indicates that faster walking MS 
patients have increased range of motion capability at the 
hip, but could not activate the hip musculature adequately 
to transition the leg into swing. In addition to decreased 
strength during late stance, peak power generation (H3) 
was lower in MS patients. During the push-off phase of 
stance, the large burst of power generation is necessary 
to accelerate the leg.29 The inability of MS patients to 
generate sufficient power at the end of stance points to 
an inability to adequately activate the flexor muscles of 
the hip. Just after midstance, there is a period of power 
absorption at the hip that signals the transition from joint 
flexion into extension.29 Peak power absorption at this 
point (H2) is also significantly lower in MS patients. 
It appears joint motion control must be attenuated in 
patients with MS since the transition from controlling the 
joint motion (eccentric muscle action of the hip flexors) 
to initiating the joint motion (concentric muscle action of 
the hip extensors) is impeded by reduced neuromuscular 
control. The moderate relationship between H2 and EDSS 
score supports the idea that transitioning from controlling 
to initiating joint motion is impaired in MS patients due 
to neurological deficits since the EDSS score reflects 
gross neurological impairment.4 This finding is also 
supported by the reduced HROM, which indicates that 
overall movement at the hip is limited to reduce the power 
generation and absorption requirements during stance. 
In studies of elderly, a decrease in ankle plantar flexor 
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power generation at late stance is compensated with an 
increase in hip power generation at the same point in the 
stance phase.6,24,30 In MS patients this compensation does 
not occur. It seems that MS patients are unable to adapt 
any other compensatory strategies to overcome reduced 
power at one joint by increasing power at another joint.
The slower walking velocity measured in MS 
patients compared with controls may be explained by the 
reduced dorsiflexor torque and accompanying reduced 
power absorption at loading response and by reduced 
ankle and hip power generation at terminal stance. These 
variables have been shown to be the most important in 
predicting performance during walking in both elderly 
and Parkinson populations.6,12,31 Like MS, Parkinson’s 
disease (PD) patients also have significantly reduced 
ankle torque, reduced hip extension, and reduced hip 
power during late stance.12,31
This study does have some limitations. This study did 
not measure lower extremity spasticity or lower extremity 
muscle strength. In future studies it would be of great 
interest to examine how spasticity and muscle strength 
are related to the gait parameters described in this article. 
Because of the many factors that can affect gait in persons 
with MS, this study did not include/exclude or classify 
subjects based on any specific walking tendencies (ie, 
drop foot or reported leg weakness). For this reason, the 
MS group is mildly affected based on the mean EDSS 
score only. Finally, gait variables were correlated with 
the gross EDSS score only and not the specific functional 
system scores. While it would be of interest to examine 
the relationship between gait variables and, for example, 
cerebellar and pyramidal signs, the focus of this article 
is to examine the biomechanical differences in gait only. 
In the future, it would be of high interest to expand these 
findings by examining the relationship between gait and 
related neurological deficits. Finally, torque and power 
variables were normalized with respect to body mass, 
but instead could have been normalized with respect to 
walking speed or leg length, for example. However, this 
study used walking speed as a covariate in the analysis 
and because the groups showed no statistical difference in 
mass or height, it is unlikely that leg length normalization 
would have altered the results.
Despite limitations, this study found extensive signifi-
cant differences in joint torques and powers of patients with 
MS compared with healthy controls. These differences 
provide a picture of the mechanical gait deficit seen in these 
patients and indicate the importance of using advanced 
gait analysis evaluation to classify disability in MS. 
Importantly, the differences in gait kinetics between MS 
patients and controls cannot be explained by differences 
in walking velocity alone since velocity was controlled in 
our statistical model. Thus, specific neuromuscular mecha-
nisms independent of walking velocity were revealed for 
this pathology including the inability to eccentrically 
control muscle activity (power absorption by the ankle 
dorsiflexors) and to concentrically generate muscle activity 
(power generation by the ankle plantar flexors and the hip 
flexors). The conclusion that the interactions between joint 
powers and walking velocity are likely more neurological 
in nature than muscular must be investigated further by 
measuring changes in muscle strength and muscle firing 
patterns during walking. The significant relationships 
between EDSS score and gait variables in the MS patients 
indicate that biomechanical gait variables are related to 
clinical disability. Thus, gait analysis could be performed 
in MS patients to support clinical decision making as is 
the case for patients with cerebral palsy.10 Gait analysis 
offers an additional tool to monitor disease status and 
progression and to determine outcomes from rehabilitation 
interventions and pharmacological treatment protocols.
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